Clinical Trial Update: PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary Angiography [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating whether simvastatin reduces contrast-induced acute kidney injury in patients with renal insufficiency undergoing coronary angiography…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Injury

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Kidney Failure | Phase 4 | Status: COMPLETED